Evaxion A (EVAX) Net Income towards Common Stockholders (2020 - 2026)
Evaxion A (EVAX) reported Net Income towards Common Stockholders of -$3.73 million for Q2 2026, compared with -$4.83 million a year earlier.
Powered by 
Analysis
Evaxion A (EVAX) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evaxion A's Net Income towards Common Stockholders came in at -$8.66 million; for FY2025, it was -$7.71 million.
- By year, Net Income towards Common Stockholders came in at -$10.57 million in FY2024, -$22.13 million in FY2023, -$23.17 million in FY2022 and -$24.53 million in FY2021.
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$8.37 million in Q4 2021 and a high of $4.62 million in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$3.63 million (Q1 2026), -$5.92 million (Q4 2025) and $4.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Evaxion A | 20.51 Mn | -45.74 Mn | - | -3.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.73 Mn |
| Mar 31, 2026 | -3.63 Mn |
| Dec 31, 2025 | -5.92 Mn |
| Sep 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | -4.83 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -3.63 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | -4.52 Mn |
| Sep 30, 2023 | -5.68 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.24 Mn |
| Dec 31, 2022 | -6.87 Mn |
| Sep 30, 2022 | -5.74 Mn |
| Jun 30, 2022 | -4.77 Mn |
| Mar 31, 2022 | -5.79 Mn |
| Dec 31, 2021 | -8.37 Mn |
| Sep 30, 2021 | -5.25 Mn |
API Access
Evaxion A Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();